PT-141
Bremelanotide with preferential MC3R/MC4R affinity for CNS melanocortin and hypothalamic signaling studies.
$100 minimum order. Free shipping over $300, otherwise $20. US domestic only. Zelle orders get an extra 5% off at checkout.
About this compound
PT-141 (Bremelanotide) is a cyclic heptapeptide with preferential affinity for MC3R and MC4R over MC1R. Unlike Melanotan-2, it shows minimal pigmentation pathway activity and primarily engages CNS melanocortin circuitry. Activates cAMP signaling in hypothalamic cell models. MC3R/MC4R vs MC1R selectivity studies, hypothalamic melanocortin pathway research, CNS receptor binding assays, and comparative pharmacology panels alongside Melanotan-2.
| CAS | 189691-06-3 |
|---|---|
| Purity | ≥99% (HPLC verified) |
| Storage | −20°C, protect from light |
| Fill | 10mg per vial |
| Form | Lyophilized powder |
| Lab results | 1 on file · latest Feb 2026 |
Certificates of analysis
Results come from Janoshik Analytical Laboratory, an independent lab. Open any result to see the full report, or look up the test ID at janoshik.com.
| Date | Test | Batch | Test ID | Link |
|---|---|---|---|---|
| Feb 2026 | PT-141 10mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #106598 | View result |
Results are from our supplier's published testing records. Dates show when each result was published. Each test covers the sample sent to the lab. See every compound on the lab results page.
More research compounds
For in vitro research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. By ordering you agree to our terms of service and research use agreement.